GOSS
Price
$1.31
Change
+$0.05 (+3.97%)
Updated
Jun 6, 04:23 PM (EDT)
Capitalization
285.26M
67 days until earnings call
IMRX
Price
$2.16
Change
+$0.11 (+5.37%)
Updated
Jun 6, 04:25 PM (EDT)
Capitalization
73.77M
61 days until earnings call
Interact to see
Advertisement

GOSS vs IMRX

Header iconGOSS vs IMRX Comparison
Open Charts GOSS vs IMRXBanner chart's image
Gossamer Bio
Price$1.31
Change+$0.05 (+3.97%)
Volume$529
Capitalization285.26M
Immuneering
Price$2.16
Change+$0.11 (+5.37%)
Volume$1K
Capitalization73.77M
GOSS vs IMRX Comparison Chart
Loading...
GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GOSS vs. IMRX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GOSS is a Buy and IMRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (GOSS: $1.25 vs. IMRX: $2.05)
Brand notoriety: GOSS and IMRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GOSS: 45% vs. IMRX: 182%
Market capitalization -- GOSS: $285.26M vs. IMRX: $73.77M
GOSS [@Biotechnology] is valued at $285.26M. IMRX’s [@Biotechnology] market capitalization is $73.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GOSS’s FA Score shows that 0 FA rating(s) are green whileIMRX’s FA Score has 0 green FA rating(s).

  • GOSS’s FA Score: 0 green, 5 red.
  • IMRX’s FA Score: 0 green, 5 red.
According to our system of comparison, GOSS is a better buy in the long-term than IMRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GOSS’s TA Score shows that 6 TA indicator(s) are bullish while IMRX’s TA Score has 5 bullish TA indicator(s).

  • GOSS’s TA Score: 6 bullish, 4 bearish.
  • IMRX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, GOSS is a better buy in the short-term than IMRX.

Price Growth

GOSS (@Biotechnology) experienced а +11.06% price change this week, while IMRX (@Biotechnology) price change was +20.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.55%. For the same industry, the average monthly price growth was +17.24%, and the average quarterly price growth was +3.49%.

Reported Earning Dates

GOSS is expected to report earnings on Aug 12, 2025.

IMRX is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+11.55% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GOSS($285M) has a higher market cap than IMRX($73.8M). GOSS YTD gains are higher at: 38.735 vs. IMRX (-6.818). GOSS has higher annual earnings (EBITDA): -39.97M vs. IMRX (-63.85M). GOSS has more cash in the bank: 295M vs. IMRX (35.9M). IMRX has less debt than GOSS: IMRX (4.08M) vs GOSS (203M). GOSS has higher revenues than IMRX: GOSS (115M) vs IMRX (0).
GOSSIMRXGOSS / IMRX
Capitalization285M73.8M386%
EBITDA-39.97M-63.85M63%
Gain YTD38.735-6.818-568%
P/E RatioN/AN/A-
Revenue115M0-
Total Cash295M35.9M822%
Total Debt203M4.08M4,972%
FUNDAMENTALS RATINGS
GOSS: Fundamental Ratings
GOSS
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GOSSIMRX
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 4 days ago
88%
Declines
ODDS (%)
Bearish Trend 8 days ago
87%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FADIX28.49N/A
N/A
Fidelity Advisor Diversified Intl M
ALCBX12.13N/A
N/A
ALPS/Smith Balanced Opportunity C
HFQCX6.70N/A
N/A
Janus Henderson Global Equity Income C
MEMKX10.70N/A
N/A
BNY Mellon Emerging Markets M
WINAX10.47N/A
N/A
Wilmington International A

GOSS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GOSS has been loosely correlated with MEIP. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GOSS jumps, then MEIP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GOSS
1D Price
Change %
GOSS100%
-0.40%
MEIP - GOSS
46%
Loosely correlated
-1.83%
CGEM - GOSS
45%
Loosely correlated
-3.64%
APVO - GOSS
41%
Loosely correlated
-3.43%
VIR - GOSS
41%
Loosely correlated
-2.37%
CLLS - GOSS
37%
Loosely correlated
+0.70%
More

IMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMRX has been loosely correlated with NUVL. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if IMRX jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMRX
1D Price
Change %
IMRX100%
+4.59%
NUVL - IMRX
41%
Loosely correlated
+1.65%
ORMP - IMRX
29%
Poorly correlated
-5.70%
SRRK - IMRX
29%
Poorly correlated
+11.13%
GOSS - IMRX
29%
Poorly correlated
-0.40%
BRTX - IMRX
27%
Poorly correlated
+0.86%
More